Searchable abstracts of presentations at key conferences in endocrinology

ea0009oc9 | Oral Communication 1: Diabetes and metabolism | BES2005

Testosterone improves funtional capacity and symptoms in men with chronic heart failure: a double blind placebo controlled trial

Malkin C , Pugh P , Jones R , van Beek E , West J , Channer K , Jones T

Chronic heart failure (CHF) is associated with maladaptive and prolonged neurohormonal and pro-inflammatory cytokine activation causing a metabolic shift favouring catabolism, vasodilator incapacity, and loss of skeletal muscle bulk and function. In men, androgens are important determinants of anabolic function and physical strength and also possess anti-inflammatory and vasodilatory properties. We conducted a randomised, double blind, placebo controlled trial of testosterone ...

ea0003p253 | Steroids | BES2002

Testosterone and skeletal muscle parameters in men with chronic heart failure

Pugh P , Jones R , Hall J , Channer K , Jones T , van Beek E

Objectives: Patients with chronic heart failure (CHF) almost universally complain of exercise intolerance due, in part, to alterations of skeletal muscle. In men, testosterone is an important determinant of muscle bulk and strength. Relative androgen deficiency in men with CHF could contribute to exercise intolerance. We studied the relationship between plasma levels of testosterone and measures of skeletal muscle bulk and strength and exercise capacity in men with CHF.<p ...